About Amryt pharma plc
Amryt Pharma Plc: Delivering Innovative Treatments for Rare Diseases
Amryt Pharma Plc is a commercial stage pharmaceutical company that is dedicated to developing and delivering innovative new treatments for people with rare diseases. The company's mission is to improve the lives of patients who suffer from these conditions by providing them with effective and safe therapies that address their unique needs.
At Amryt, we understand the challenges faced by patients with rare diseases, as well as their families and caregivers. These conditions are often poorly understood, misdiagnosed or underdiagnosed, and there are few treatment options available. This can lead to significant physical, emotional, and financial burdens for those affected.
That's why we're committed to developing new therapies that can make a real difference in the lives of these patients. Our focus is on identifying unmet medical needs in rare diseases where there are no or limited treatment options available. We then work tirelessly to develop innovative solutions that can help address these needs.
Our approach involves leveraging our expertise in drug development and commercialization to bring promising new therapies through clinical trials and regulatory approval processes. We also collaborate closely with patient advocacy groups, healthcare providers, regulators, and other stakeholders throughout the drug development process.
One of our key areas of focus is on treating epidermolysis bullosa (EB), a group of rare genetic skin disorders characterized by fragile skin that blisters easily in response to minor trauma or friction. EB affects approximately 500,000 people worldwide and currently has no cure.
We have developed two products for EB: AP101 (Oleogel-S10) which has been granted orphan drug designation by both the US FDA & European Medicines Agency (EMA) & AP103 which has been granted Orphan Drug Designation from EMA . Both products have shown promising results in clinical trials so far ,and we hope they will soon be approved for use in treating this debilitating condition.
In addition to our work on EB treatments ,we also have several other programs underway targeting various other rare diseases such as Acromegaly ,Cushing’s Syndrome etc .
At Amryt Pharma Plc., we believe that everyone deserves access to safe and effective treatments for their medical conditions – regardless of how rare those conditions may be .We remain committed towards bringing innovative solutions forward so as improve quality life of people suffering from Rare Diseases .
amrytpharma.com